Biogen and Target ALS Launch $20M Corporate Funding Challenge

The Target ALS Foundation has received a $5M donation from Biogen to fund preclinical ALS research across the Foundation’s network of academic laboratories. These funds are the first in the Target ALS Industry Fund for ALS Research, which aims to raise a total of $20M from additional industry partners to fund precompetitive ALS research with a view toward fueling drug development programs in biotechnology and pharmaceutical companies. Biogen will also match 50% of contribution received from industry partners through 2018.

Click here to read more.

disease-als topic-randd
Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail